Anyone more learned than myself who can provide the current status of our Fragile X trial? Last i can seem to find is the Chairman's address release on 29/06/2017 in which Dr T mentioned they are designing the next clinical trial. No updates on this. I feel the Rett valuation for a deal would be a fait accompli. The Fragile X is the unknown and would be the complex negotiating points.
Anyone more learned than myself who can provide the current...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.01 |
Change
-0.010(0.08%) |
Mkt cap ! $1.662B | |||
| Open | High | Low | Value | Volume |
| $13.06 | $13.26 | $12.81 | $5.865M | 451.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 14541 | $13.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.02 | 2438 | 1 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |